Business
The Lewy Body Dementia Association and Acadia Pharmaceuticals to Release Educational Version of the Highly Acclaimed Robin Williams Documentary, “Robin’s Wish”
ATLANTA & SAN DIEGO--(BUSINESS WIRE)-- The Lewy Body Dementia Association (LBDA) and Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) announced today an exclusive
About this update from Acadia Pharmaceuticals Inc.
[{"type":"text","content":" ATLANTA & SAN DIEGO--(BUSINESS WIRE)--\nThe Lewy Body Dementia Association (LBDA) and Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) announced today an exclusive partnership on the production and release of a disease education adaptation of the new film Robin’s Wish©, a documentary detailing the late actor Robin Williams’ courageous battle with the neurodegenerative disorder, Lewy body dementia (LBD).\nThis press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201014005922/en/\nThe film, SPARK - Robin Williams and his Battle with Lewy Body Dementia©, will go beyond describing LBD through the lens of Williams’ personal experience and delve into the neurobiology of the disease and associated symptoms to help educate the medical community on the second most common form of degenerative dementia. Lewy body dementia is also the most misdiagnosed dementia, and healthcare provider education is needed to enable early recognition, diagnosis and treatment.\n\nWhile the full-length film is available on demand and via digital channels, the adaptation, will be available to major academic research institutions and universities as part of educational programming and outreach to the healthcare professionals, the LBD community and general public. The film will be available starting in late October.\n\n“Robin Williams unknowingly battled LBD and unfortunately, he is not alone. This version of the documentary will not only raise awareness of Lewy body dementia, but reinforce the importance of early symptom recognition, diagnosis and effective management of this devastating disease, and can serve as a key element in our educational offering,” said Todd Graham, Executive Director, Lewy Body Dementia Association.\n\nApproximately 8 million people in the United States are living with dementia, although only half are diagnosed with the condition.1,2,3 In addition to cognitive decline, neuropsychiatric symptoms, including hallucinations, delusions and changes in behavior, are also common. Lewy body dementia affects approximately 1.4 million people and their families in the United States alone.4\n\n“The use of scientific storytelling is an important opportunity to increase knowledge within the medical community on the need for better diagnostic and disease management solutions. Our goal is to ensure people st...